BR100 Decreased By (-0.38%)
BR30 Decreased By (-0.46%)
KSE100 Decreased By (-0.42%)
KSE30 Decreased By (-0.52%)
AGHA 7.40 Decreased By ▼ -0.16 (-2.12%)
BECO 5.06 Decreased By ▼ -0.03 (-0.59%)
BML 56.43 Increased By ▲ 1.45 (2.64%)
BOP 32.64 Decreased By ▼ -0.34 (-1.03%)
CNERGY 10.29 Increased By ▲ 0.19 (1.88%)
CSIL 5.36 Increased By ▲ 0.23 (4.48%)
FCCL 51.74 Increased By ▲ 0.49 (0.96%)
FFL 16.49 Increased By ▲ 0.31 (1.92%)
FNEL 1.21 Increased By ▲ 0.02 (1.68%)
KEL 7.14 Increased By ▲ 0.08 (1.13%)
KOSM 6.05 Increased By ▲ 0.51 (9.21%)
LOTCHEM 26.81 Decreased By ▼ -2.31 (-7.93%)
MLCF 88.17 Decreased By ▼ -0.65 (-0.73%)
NBP 193.18 Decreased By ▼ -4.31 (-2.18%)
NCPL 55.31 Increased By ▲ 0.29 (0.53%)
NPL 64.65 Decreased By ▼ -0.23 (-0.35%)
OGDC 310.38 Decreased By ▼ -1.57 (-0.5%)
PACE 10.38 Increased By ▲ 0.17 (1.67%)
PAEL 40.85 Decreased By ▼ -0.14 (-0.34%)
PIBTL 15.85 Decreased By ▼ -0.11 (-0.69%)
PPL 211.10 Decreased By ▼ -1.56 (-0.73%)
PRL 53.14 Increased By ▲ 0.60 (1.14%)
PTC 68.07 Decreased By ▼ -1.01 (-1.46%)
SSGC 24.85 Decreased By ▼ -0.25 (-1%)
TBL 9.50 Decreased By ▼ -0.12 (-1.25%)
TELE 8.29 Decreased By ▼ -0.03 (-0.36%)
TPL 18.29 Increased By ▲ 0.54 (3.04%)
TPLP 12.97 Decreased By ▼ -0.25 (-1.89%)
TREET 21.43 Decreased By ▼ -0.31 (-1.43%)
TRG 58.97 Increased By ▲ 2.08 (3.66%)
By

PARIS: French pharmaceutical group Sanofi announced on Tuesday that it is being investigated by the EU as part of a probe into its practices in the hugely-competitive flu vaccine sector.

The EU Commission said earlier on Tuesday it was carrying out surprise inspections of a company active in the vaccines sector. It did not name the firm nor say in which country the raids were taking place, though it specified investigators were joined by competition authorities of the member state affected.

The European Commission said it has “concerns that the inspected company may have violated EU antitrust rules that prohibit abuses of a dominant market position”. In a statement, Sanofi said it “confirms that representatives of the European Commission visited Sanofi’s headquarters in France and Germany on September 29, 2025, as part of an investigation into its conduct in the seasonal flu vaccine sector”

Comments

Comments are closed for this article.